Everything to know about cystic fibrosis and what causes it
Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
Healio7h
FDA grants brensocatib priority review for bronchiectasis
The FDA has granted priority review to brensocatib to treat patients with non-cystic fibrosis bronchiectasis, according to a ...
BioSpace4h
Boehringer Ingelheim’s Lung Fibrosis Drug Scores Second Late-Stage Win
Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...
FierceBiotech12h
Pliant pauses phase 2 lung fibrosis trial on advice of safety committee
Pliant Therapeutics has pumped the breaks on a mid-stage trial of its lead liver disease drug on the advice of its safety ...
FierceBiotech6h
Boehringer widens fibrosis drug’s approval path after boosting lung function in 2nd phase 3 trial
Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in a related lung disease leading the drugmaker to expand the indications it ...
ENDPOINTS NEWS8h
Pli­ant paus­es Phase 2b lung fi­bro­sis study af­ter safe­ty board rec­om­men­da­tion, shares plum­met
Pli­ant Ther­a­peu­tics has slammed the brakes on en­roll­ment and dos­ing in a mid-stage study of its lung dis­ease ...
ENDPOINTS NEWS4h
Boehringer In­gel­heim touts suc­cess in sec­ond Phase 3 lung fi­bro­sis tri­al
Boehringer Ingelheim said its experimental treatment for a chronic lung disease succeeded in a pivotal study, and it's taking ...